Skip to main content
Top
Published in: Infectious Diseases and Therapy 3/2024

Open Access 23-02-2024 | Pseudomonas Aeruginosa | Case Report

Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices

Authors: Abiu Sempere, Gabriela Chullo, Sabina Herrera, Jorge Boán, Elisa Pose, María Londoño, Virginia Hernandez-Gea, Miguel Ángel Verdejo, Juan Carlos García-Valdecasas, Cristina Pitart, Yiliam Fundora, Alex Soriano, Marta Bodro

Published in: Infectious Diseases and Therapy | Issue 3/2024

Login to get access

Abstract

n-Butyl-2-cyanoacrylate (NCBA) is an effective therapeutic option for bleeding gastric varices but can sometimes be associated with adverse effects. Persistent bacteraemia is an unusual complication with a high mortality rate. We report the case of a 34-year-old man with history of cirrhosis due to Wilson’s disease and severe portal hypertension who was hospitalized as a result of upper gastrointestinal bleeding secondary to fundic varices that were treated with NCBA. Eight weeks after the bleeding episode he was readmitted with a 14-day history of fever and chills. Pseudomonas aeruginosa was isolated from blood cultures. He presented with persistent P. aeruginosa bacteraemia despite correct antibiotic treatment. A PET-CT scan was performed to rule out infection source, and inflammatory changes at the NCBA site plug were found. A presumptive diagnosis of NCBA plug infection was considered. The case was evaluated by multidisciplinary board and indicated liver transplantation as treatment. However, the patient’s bacteraemia persisted and therefore a vertical gastrectomy to remove the NCBA plug was performed. P. aeruginosa was also isolated from the plug. The patient was discharged with ceftazidime plus ciprofloxacin to complete 6 weeks after surgery and he remained asymptomatic. Any foreign material such as NCBA is susceptible to being infected and should be considered in patients with persistent breakthrough bloodstream infections. The individualized treatment is recommended in this complex scenario.
Literature
1.
go back to reference de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII faculty. BAVENO VII—renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74.CrossRefPubMed de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII faculty. BAVENO VII—renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74.CrossRefPubMed
2.
go back to reference Jun CH, Kim KR, Yoon JK, et al. Clinical outcomes of gastric variceal obliteration using n-butyl-2-cyanoacrylate in patients with acute gastric variceal hemorrhage. Korean J Intern Med. 2014;29(4):437–44.CrossRefPubMedPubMedCentral Jun CH, Kim KR, Yoon JK, et al. Clinical outcomes of gastric variceal obliteration using n-butyl-2-cyanoacrylate in patients with acute gastric variceal hemorrhage. Korean J Intern Med. 2014;29(4):437–44.CrossRefPubMedPubMedCentral
3.
go back to reference Garcia-Pagan JC, Barrufet M, Cardenas A. Management of gastric varices. Clin Gastroenterol Hepatol. 2014;12:919–28.CrossRefPubMed Garcia-Pagan JC, Barrufet M, Cardenas A. Management of gastric varices. Clin Gastroenterol Hepatol. 2014;12:919–28.CrossRefPubMed
4.
go back to reference Chen WC, Hou MC, Lin HC, et al. Bacteraemia after endoscopic injection of n-butyl-2-cyano-acrylate for gastric variceal bleeding. Gastrointest Endosc. 2001;54:214–8.CrossRefPubMed Chen WC, Hou MC, Lin HC, et al. Bacteraemia after endoscopic injection of n-butyl-2-cyano-acrylate for gastric variceal bleeding. Gastrointest Endosc. 2001;54:214–8.CrossRefPubMed
5.
go back to reference Bonilha DQ, Correia LM, Monaghan M, Lenz L, Santos M, Libera ED. Prospective study of bacteraemia rate after elective band ligation and sclerotherapy with cyanoacrylate for esophageal varices in patients with advanced liver disease. Arq Gastroenterol. 2011;48(4):248–51.CrossRefPubMed Bonilha DQ, Correia LM, Monaghan M, Lenz L, Santos M, Libera ED. Prospective study of bacteraemia rate after elective band ligation and sclerotherapy with cyanoacrylate for esophageal varices in patients with advanced liver disease. Arq Gastroenterol. 2011;48(4):248–51.CrossRefPubMed
6.
go back to reference Wahl P, Lammer F, Conen D, Schlumpf R, Bock A. Septic complications after injection of n-butyl-2-cyanoacrylate: report of two cases and review. Gastrointest Endosc. 2004;59(7):911–6.CrossRefPubMed Wahl P, Lammer F, Conen D, Schlumpf R, Bock A. Septic complications after injection of n-butyl-2-cyanoacrylate: report of two cases and review. Gastrointest Endosc. 2004;59(7):911–6.CrossRefPubMed
7.
go back to reference Lidove O, Gervais A, Malphettes M, Sauvanet A, Moretti JL, Papo T. Infection after cyanoacrylate injection: a fatal complication in a patient with portal hypertension associated with common variable immunodeficiency. Endoscopy. 2007;39(Suppl 1):E180–1.CrossRefPubMed Lidove O, Gervais A, Malphettes M, Sauvanet A, Moretti JL, Papo T. Infection after cyanoacrylate injection: a fatal complication in a patient with portal hypertension associated with common variable immunodeficiency. Endoscopy. 2007;39(Suppl 1):E180–1.CrossRefPubMed
8.
go back to reference Wright G, Matull WR, Zanbreanu L, et al. Recurrent bacteraemia due to retained embolized glue following variceal obliteration. Endoscopy. 2009;41:56–7.CrossRef Wright G, Matull WR, Zanbreanu L, et al. Recurrent bacteraemia due to retained embolized glue following variceal obliteration. Endoscopy. 2009;41:56–7.CrossRef
10.
go back to reference Reuken PA, Bruns T, Zimmer B, et al. Recurrent fever and bacteraemia after endoscopic variceal haemostasis with cyanoacrylate: a case report. Infection. 2011;40(3):351–3.CrossRefPubMed Reuken PA, Bruns T, Zimmer B, et al. Recurrent fever and bacteraemia after endoscopic variceal haemostasis with cyanoacrylate: a case report. Infection. 2011;40(3):351–3.CrossRefPubMed
11.
go back to reference Joo K, Hyun IY, Baek JH, Chung MH, Lee JS. Detection of an infected n-butyl-2-cyanoacrylate plug by F-18 FDG PET/CT scan in a patient who received endoscopic intervention for gastric variceal bleeding. Infect Chemother. 2013;45(2):230–3.CrossRefPubMedPubMedCentral Joo K, Hyun IY, Baek JH, Chung MH, Lee JS. Detection of an infected n-butyl-2-cyanoacrylate plug by F-18 FDG PET/CT scan in a patient who received endoscopic intervention for gastric variceal bleeding. Infect Chemother. 2013;45(2):230–3.CrossRefPubMedPubMedCentral
12.
go back to reference Randi BA, Ninomiya DA, Nicodemo EL, Lopes BC, Cançado ER, Levin AS. Recurrent bacteraemia after injection of n-butyl-2-cyanoacrylate for treatment of bleeding gastric varices: a case report and review of the literature. BMC Res Notes. 2015;19(8):692.CrossRef Randi BA, Ninomiya DA, Nicodemo EL, Lopes BC, Cançado ER, Levin AS. Recurrent bacteraemia after injection of n-butyl-2-cyanoacrylate for treatment of bleeding gastric varices: a case report and review of the literature. BMC Res Notes. 2015;19(8):692.CrossRef
13.
go back to reference Briceño E, Maturana G, Irarrázaval MJ, Larraín S, Eymin G. Resección quirúrgica de tapón de cianoacrilato variceal infectado posterior a esclerosis endoscópica de várices gástricas. Caso clínico [Removal of an infected gastric cyanoacrylate plug. Report of one case]. Rev Med Chile. 2020;148(11):1674–8.CrossRefPubMed Briceño E, Maturana G, Irarrázaval MJ, Larraín S, Eymin G. Resección quirúrgica de tapón de cianoacrilato variceal infectado posterior a esclerosis endoscópica de várices gástricas. Caso clínico [Removal of an infected gastric cyanoacrylate plug. Report of one case]. Rev Med Chile. 2020;148(11):1674–8.CrossRefPubMed
Metadata
Title
Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices
Authors
Abiu Sempere
Gabriela Chullo
Sabina Herrera
Jorge Boán
Elisa Pose
María Londoño
Virginia Hernandez-Gea
Miguel Ángel Verdejo
Juan Carlos García-Valdecasas
Cristina Pitart
Yiliam Fundora
Alex Soriano
Marta Bodro
Publication date
23-02-2024

Other articles of this Issue 3/2024

Infectious Diseases and Therapy 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.